Suggestions
Ola Landgren
Professor of Medicine, University of Miami; Chief, Myeloma Program; Leader, Experimental Therapeutics Program
C. Ola Landgren, M.D., Ph.D. is a distinguished medical professional with extensive experience in the field of hematology and oncology.1 He currently holds several important positions at the University of Miami:
- Professor of Medicine
- Chief of the Myeloma Division
- Leader of the Experimental Therapeutics Program234
Dr. Landgren has nearly three decades of leadership experience in translational cancer medicine.1 His expertise is particularly focused on myeloma, a type of blood cancer. As a hematology/oncology specialist with both MD and PhD degrees, he brings a wealth of knowledge and experience to his roles.1
Prior to his current position at the University of Miami, which he assumed in November 2020, Dr. Landgren was associated with the National Cancer Institute.5 This background suggests a strong foundation in cancer research and treatment.
Dr. Landgren is actively involved in advancing myeloma research and treatment. He frequently shares updates and insights about myeloma on professional platforms, often using the hashtag #mmsm (likely standing for Multiple Myeloma Social Media).46 His work appears to be well-respected in the field, with colleagues congratulating him on his achievements and advancements in myeloma research.6
